IPO registrations (S-1, F-1) · Registrants

COLLAGENEX PHARMACEUTICALS INC

SEC CIK
1012270 · filings on EDGAR ↗
Registration
Form S-1, first filed 1996-05-24, last 1997-04-02; 1 initial registration, 4 amendments
Outcome
Final prospectus filed 1996-06-21
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
41 UNIVERSITY DRIVE, Newton, PA 18940
EIN
52-1758016
EDGAR entity type
operating
Insiders and CEO pay
COLLAGENEX PHARMACEUTICALS INC on the corporate pages

Offering terms

Final price
$10.00 per share (424B1 filed 1996-06-21)
Shares sold
2,000,000
Gross proceeds
$20,000,000 before underwriting discounts and any over-allotment option
Lead underwriters
Alex. Brown & Sons

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 7

FiledFormWhat it isName as filedEDGAR
1996-05-24S-1/AS-1/A (amendment)COLLAGENEX PHARMACEUTICALS INC0000893220-96-000888 ↗
1996-06-20S-1/AS-1/A (amendment)COLLAGENEX PHARMACEUTICALS INC0000893220-96-001031 ↗
1996-06-20S-1/AS-1/A (amendment)COLLAGENEX PHARMACEUTICALS INC0000893220-96-001032 ↗
1996-06-21424B1424B1 (final prospectus)COLLAGENEX PHARMACEUTICALS INC0000893220-96-001046 ↗
1997-03-28S-1S-1 (registration)COLLAGENEX PHARMACEUTICALS INC0000893220-97-000630 ↗
1997-04-02S-1/AS-1/A (amendment)COLLAGENEX PHARMACEUTICALS INC0000893220-97-000693 ↗
1997-04-04424B1424B1 (final prospectus)COLLAGENEX PHARMACEUTICALS INC0000893220-97-000701 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
1996-06-20S-1/Aregistration statement$10.002,000,000$20,000,0001from the submission text; price sentence, shares headline, proceeds computed, cover names 1document ↗
1996-06-21424B1final prospectus$10.002,000,000$20,000,0001from the submission text; price sentence, shares headline, proceeds computed, cover names 1document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
EASTON ROBERT JDirector62006–2007
BROADBENT NANCY COfficerCFO and Treasurer72006–2008
PFEIFFER DAVID FOfficerSr. VP, Sales and Marketing122006–2008
Powell Andrew Kenneth WilliamOfficerVP, G. Counsel and Corp. Sec.62006–2007
STEWART COLIN WDirector,OfficerPresident and CEO22006–2007
THEOBALD KLAUSOfficerSr VP & Chief Medical Officer42006–2007
BARNETT PETER RDirector32006–2007
Beardsley Robert ADirector22006–2007
BLACK ROBERT CDirector22006–2007
DAVERMAN JAMES EDirector52006–2007
LASEZKAY GEORGE MDirector22006–2007
O SHEA W JAMESDirector22006–2007
Ford James GregoryOfficerVP, Business Development72006–2007
Galderma Laboratories, Inc.TenPercentOwner12008

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationCollagenex Pharmaceuticals, Inc.PAState business registriesname and state
Business registrationCOLLAGENEX PHARMACEUTICALS, INC.PAState business registriesname and state
SEC filerCOLLAGENEX PHARMACEUTICALS INCSEC filers (EDGAR)CIK (EXACT)
Trademark ownerCollaGenex Pharmaceuticals, Inc.PATrademarks (USPTO)name and state

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, PA first:

More with this interest.

In other datasets, the same topic (Health) in PA:

Interests: Pharmaceutical Preparations · Health